VIVUS, Inc. - VVUS - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 12, 2013

VIVUS, Inc. - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
VVUS	Nasdaq	2834	http://www.vivus.com/	12.30 -0.24
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for VIVUS, Inc. 25 Belt-Busting Obesity Facts - May 18th, 2013 6:01 am VIVUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stateme - May 16th, 2013 8:22 am InPlay: Vivus prices offering of $220 mln aggregate principal amount of 4.50% convertible senior unsecured notes due May 1, 2020 - May 16th, 2013 5:02 am VIVUS Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes - May 16th, 2013 5:00 am Weight Loss Isn't Just for Looking Good Anymore - May 15th, 2013 5:04 pm Is Vivus a Buy at These Prices? - May 15th, 2013 11:28 am VIVUS INC Financials - May 15th, 2013 11:04 am Vivus to sell $200 million in convertible debt - May 15th, 2013 9:38 am Vivus to sell $200 million in convertible debt - May 15th, 2013 9:38 am Vivus - Mild Drama Continues - May 15th, 2013 8:18 am Will Obesity Drugs Gain Soon? - May 15th, 2013 6:42 am VIVUS Announces Proposed Offering of Convertible Senior Notes - May 15th, 2013 5:00 am VIVUS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - May 14th, 2013 10:06 pm Analysts: Market Is Beginning to Recognize Tesla and 3 Other Research Notes to Check Out - May 14th, 2013 12:19 pm VIVUS Announces Scientific Presentations - May 14th, 2013 5:00 am Looking at Arena Following Sell-Off - May 14th, 2013 3:49 am Vivus Starting To Gain The Advantage Over Arena - May 14th, 2013 3:42 am Shorting Arena Is Not a Good Idea Now - May 13th, 2013 11:16 pm Arena, Vivus, And Off-Label Prescriptions - May 13th, 2013 11:08 pm Vivus Adds Two New Directors to Board Amid Pressure - May 13th, 2013 2:18 pm View All Current Headlines >>